Blaas, Isaac
8  results:
Search for persons X
?
2

Rituximab‐treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
British Journal of Haematology.  197 (2022)  6 - p. 697-708 , 2022
 
?
4

Prevalent and immunodominant CD8 T cell epitopes are conser..:

Meyer, Saskia ; Blaas, Isaac ; Bollineni, Ravi Chand...
Meyer, Saskia Blaas, Isaac Bollineni, Ravi Chand Delic-Sarac, Marina Tran, Trung Knetter, Cathrine Dai, Kezheng Madssen, Torfinn Støve Vaage, John T. Gustavsen, Alice Yang, Weiwen Nissen-Meyer, Lise Sofie Haug Douvlataniotis, Karolos Laos, Maarja Nielsen, Morten Milek Thiede, Bernd Søraas, Arne Vasli Lund Lund-Johansen, Fridtjof Rustad, Even Holth Olweus, Johanna . Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants. Cell reports. 2023, 42(1).  , 2023
 
?
5

Rituximab-treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
Riise, Jon Meyer, Saskia Blaas, Isaac Chopra, Adity Tran, Trung Delic-Sarac, Marina Hestdalen, Malu Lian Brodin, Ellen Elisabeth Rustad, Even Holth Dai, Ke-Zheng Vaage, John T. Nissen-Meyer, Lise Sofie Haug Sund, Fredrik Wader, Karin Fahl Bjørnevik, Anne Turid Meyer, Peter Albert Nygaard, Gro Owren König, Marton Smeland, Sigbjørn Lund-Johansen, Fridtjof Olweus, Johanna Kolstad, Arne . Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. British Journal of Haematology. 2022, 197(6), 697-708.  , 2022
 
?
6

Rituximab-treated patients with lymphoma develop strong CD8..:

Riise, Jon ; Meyer, Saskia ; Blaas, Isaac...
British Journal of Haematology. 2022, 197 (6), 697-708..  , 2022
 
?
 
?
8

Prevalent and immunodominant CD8 T cell epitopes are conser..:

Saskia Meyer ; Isaac Blaas ; Ravi Chand Bollineni...
http://www.sciencedirect.com/science/article/pii/S2211124723000062.  , 2023
 
1-8